 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study |
| Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein |
|
Intest Res. 2022;20(1):72-77. Published online February 3, 2021 DOI: https://doi.org/10.5217/ir.2020.00117 |
|
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study Intestinal Research. 2022;20(1):72-77  P296 vedolizumab Does Not Increase Risk of Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease Using vedolizumab: a Retrospective Cohort Study Journal of Crohn's and Colitis. 2022;16(Supplement_1):i326-i326 Sa1806 - Vedoizumab Does not Increase Perioperative Surgical Complications in Patients with Inflammatory Bowel Disease Gastroenterology. 2018;154(6):S-402 Corrigendum to Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study Inflammatory Bowel Diseases. 2018;24(12):2657-2657 Which biologic agents increase perioperative complications in patients with inflammatory bowel disease? Intestinal Research. 2022;20(1):1-2 Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review The Surgeon. 2021;19(5):e153-e167 P885 Does long term corticosteroid use increase the risk of femur fracture in Inflammatory Bowel Disease patients? : A nationwide population-based cohort study Journal of Crohn's and Colitis. 2023;17(Supplement_1):i1003-i1004 DOP49 Effectiveness and safety of vedolizumab in a matched cohort of elderly and young Inflammatory Bowel Disease patients - LIVE Study-Group Journal of Crohn's and Colitis. 2021;15(Supplement_1):S085-S085 Su1864 VEDOLIZUMAB IS SAFE IN VETERAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE OVER AGE 65: RETROSPECTIVE COHORT Gastroenterology. 2020;158(6):S-680 Fr524 EFFICACY OF VEDOLIZUMAB IN A NATIONWIDE COHORT OF ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS Gastroenterology. 2021;160(6):S-346 |
